Abstract
Ikaros, a zinc finger transcription factor, is essential for lymphoid development. Mutant mice expressing dominant-negative Ikaros gene (Ikaros) isoforms develop an aggressive form of lymphoid malignancies. We examined the expression of Ikaros isoforms in 11 leukemic cell lines and adult acute lymphoblastic leukemia cells from 36 patients with B-precursor acute lymphoblastic leukemia (pre-B ALL) and nine with T-precursor acute lymphoblastic leukemia (pre-T ALL), using reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. In one pre-B ALL cell line, INC cells, and primary leukemic cells from 16 patients with pre-B ALL, we found the predominant expression of a non-DNA-binding Ikaros isoform, Ik-6. However, Ik-6 was not detected in pre-T ALL cells. All of pre-B ALL cells expressing Ik-6 were CD10+, whereas CD10− pre-B ALL cells did not express Ik-6. The expression of Ik-6 was not related to karyotype abnormalities such as t(9;22) and t(4;11). Proteins from the cells that expressed Ik-6 alone failed to bind to the Ikaros protein-specific binding sequence in DNA. Ikaros proteins lacking the DNA binding sequences were detected in the cytoplasm but not in the nucleus of the cells. When INC and primary pre-B ALL cells that express Ik-6 alone were irradiated and cultured in the absence of serum, these cells produced functional Ikaros isoforms, Ik-1 and Ik-2. Purified CD19+ CD10− and CD19+ CD10+ cells from normal human bone marrow did not express Ik-6. The predominant expression of Ik-6, which is the result of post-transcription dysregulation, is characteristic of adult pre-B ALL, especially CD10+ pre-B ALL.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kozmik Z, Wang S, Dorfler P, Adams B, Busslinger M . The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP Mol Cell Biol 1992 12: 2662–2672
Urbánek P, Wang Z-Q, Fetka I, Wagner EF, Busslinger M . Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP Cell 1994 79: 901–912
Lin H, Grosschedl R . Failure of B-cell differentiation in mice lacking the transcription factor EBF Nature 1995 376: 263–267
Zhuang Y, Soriano P, Weintraub H . The helix–loop–helix gene E2A is required for B cell formation Cell 1994 79: 875–884
Scott EW, Simon MC, Anastasi J, Singh H . Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages Science 1994 265: 1573–1577
Thévenin C, Lucas BP, Kozlow EJ, Kehrl JH . Cell type- and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter J Biol Chem 1993 268: 5949–5956
Georgopoulos K, Moore DD, Derfler B . Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment Science 1992 258: 808–812
Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE . RAG-1-deficient mice have no mature B and T lymphocytes Cell 1992 68: 869–877
Shinkai Y, Rathbun G, Lam K-P, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, Alt FW . RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement Cell 1992 68: 855–867
Molnár Á, Georgopoulos K . The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins Mol Cell Biol 1994 14: 8292–8303
Winandy S, Wu P, Georgopoulos K . A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma Cell 1995 83: 289–299
Klug CA, Morrison SJ, Masek M, Hahm K, Smale ST, Weissman IL . Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochromatin in immature lymphocytes Proc Natl Acad Sci USA 1998 95: 657–662
Sun L, Heerema N, Crotty L, Wu X, Navara C, Vassilev A, Sensel M, Reaman GH, Uckun FM . Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia Proc Natl Acad Sci USA 1999 96: 680–685
Nakase K, Ishimaru F, Avitahl N, Dansako H, Matsuo K, Fujii K, Sezaki N, Nakayama H, Yano T, Fukuda S, Imajoh K, Takeuchi M, Miyata A, Hara M, Yasukawa M, Takahashi I, Taguchi H, Matsue K, Nakao S, Niho Y, Takenaka K, Shinagawa K, Ikeda K, Niiya K, Harada M . Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia Cancer Res 2000 60: 4062–4065
Nishii K, Katayama N, Miwa H, Shikami M, Masuya M, Shiku H, Kita K . Survival of human leukaemic B-cell precursors is supported by stromal cells and cytokines: association with the expression of bcl-2 protein Br J Haematol 1999 105: 701–710
Foon KA, Todd RF III . Immunologic classification of leukemia and lymphoma Blood 1986 68: 1–31
Nishii K, Kita K, Miwa H, Shikami H, Taniguchi M, Usui E, Katayama N, Shiku H . Expression of B-cell associated transcription factors in precursor B-cell acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype Int J Hematol 2000 71: 372–378
Lemmers B, Arnoulet C, Fossat C, Chambost H, Sainty D, Gabert J, Schiff C . Fine characterization of childhood and adult acute lymphoblastic leukemia (ALL) by a proB and preB surrogate light chain-specific mAb and a proposal for a new B cell ALL classification Leukemia 2000 14: 2103–2111
Ohishi K, Katayama N, Mitani H, Araki H, Masuya M, Suzuki H, Hoshino N, Miyashita H, Nishii K, Kageyama S-I, Minami N, Shiku H . Efficient ex vivo generation of human dendritic cells from mobilized CD34+ peripheral blood progenitors Int J Hematol 2001 74: 287–296
Molnár Á, Wu P, Largespada DA, Vortkamp A, Scherer S, Copeland NG, Jenkins NA, Bruns G, Georgopoulos K . The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse J Immunol 1996 156: 585–592
Taniguchi M, Oka K, Hiasa A, Yamaguchi M, Ohno T, Kita K, Shiku H . De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation Blood 1998 91: 1145–1151
Shikami M, Miwa H, Nishii K, Takahashi T, Sekine T, Mahmud N, Nishikawa M, Shiku H, Kamada N, Kita K . Low BCL-2 expression in acute leukemia with t(8;21) chromosomal abnormality Leukemia 1999 13: 358–368
Sun L, Goodman PA, Wood CM, Crotty M-L, Sensel M, Sather H, Navara C, Nachman J, Steinherz PG, Gaynon PS, Seilbel N, Vassilev A, Juran BD, Reaman GH, Uckun FM . Expression of aberrantly spliced oncogenic Ikaros isoforms in childhood acute lymphoblastic leukemia J Clin Oncol 1999 17: 3753–3766
Sun L, Liu A, Georgopoulos K . Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development EMBO J 1996 15: 5358–5369
Sun L, Crotty M-L, Sensel M, Sather H, Navara C, Nachman J, Steinherz PG, Gaynon PS, Seibel N, Mao C, Vassilev A, Reaman GH, Uckun FM . Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia Clin Cancer Res 1999 7: 2112–2120
Payne KJ, Nicolas J-H, Zhu JY, Barsky LW, Crooks GM . Cutting edge: predominant expression of a novel Ikaros isoform in normal human hemopoiesis J Immunol 2001 167: 1867–1870
Daniel PT . Dissecting the pathway to death Leukemia 2000 14: 2035–2044
O'Gorman DM, Cotter TG . Molecular signals in anti-apoptotic pathways Leukemia 2001 15: 21–34
Georgopoulos K, Bigby M, Wang J-H, Molnar A, Wu P, Winandy S, Sharpe A . The Ikaros gene is required for the development of all lymphoid lineages Cell 1994 79: 143–156
Nakayama H, Ishimaru F, Avitahl N, Sezaki N, Fujii N, Nakase K, Ninomiya Y, Harashima A, Minowada J, Tsuchiyama J, Imajoh K, Tsubota T, Fukuda S, Sezaki T, Kojima K, Hara M, Takimoto H, Yorimitsu S, Takahashi I, Miyata A, Taniguchi S, Tokunaga Y, Gondo H, Niho Y, Nakao S, Kyo T, Dohy H, Kamada N, Harada M . Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia Cancer Res 1999 59: 3931–3934
Greaves M . Molecular genetics, natural history and the demise of childhood leukaemia Eur J Cancer 1999 35: 173–185
Wiemels JL, Ford AM, van Wering ER, Postma A, Greaves M . Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero Blood 1999 94: 1057–1062
Acknowledgements
We thank Professor MF Greaves and Dr T Ford (Leukemia Research Fund Centre at the Institute of Cancer Research, London, UK) for helpful discussion. We also thank Professor K Georgopoulos (Massachusetts General Hospital, Harvard Medical School, Boston, MA) for providing the anti-Ikaros antibody and we thank Ms C Atsumaru (Fujisawa Pharmaceutical Co Ltd, Osaka, Japan) for providing technical advice. This work was supported by research grants from the Ministry of Education, Culture, Sports, Science, and Technology and from the Ministry of Health, Labour, and Welfare, Japan and a Grant-in-Aid from the Mie Medical Research Foundation.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nishii, K., Katayama, N., Miwa, H. et al. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia. Leukemia 16, 1285–1292 (2002). https://doi.org/10.1038/sj.leu.2402533
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402533
Keywords
This article is cited by
-
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study
Leukemia (2016)
-
MicroRNAs in B cell development and malignancy
Journal of Hematology & Oncology (2012)
-
Expression of dominant-negative Ikaros isoforms and associated genetic alterations in Chinese adult patients with leukemia
Annals of Hematology (2012)
-
Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML
Leukemia (2003)
-
Reply to SE Langabeer et al
Leukemia (2003)